BTK and Miyoshi myopathy: Mechanistically, we found that BTK signaling is involved in the macrophage’s CXCL13 up-regulation in response to MM-mediated stimulation, while BTK inhibition using ibrutinib effectively abrogated the increased CXCL13 production.